PRINCIPLES OF THE PROLACTIN/VASOINHIBIN AXIS.
Mexico. In Am J Physiol Regul Integr Comp Physiol, 26 Sep 2015
UNASSIGNED: The hormonal family of vasoinhibins, which derive from the anterior pituitary hormone prolactin, are known for their inhibiting effects on blood vessel growth, vasopermeability, and vasodilation.
Alterations in the serum biomarkers belonging to different metabolic systems of fish (Oreochromis niloticus) after Cd and Pb exposures.
Adana, Turkey. In Environ Toxicol Pharmacol, 06 Sep 2015
In this study, freshwater fish Oreochromis niloticus were individually exposed Cd or Pb using acute (10μM, 2 d) and chronic (20μM, 20 d) exposure protocols to investigate the alterations in serum parameters (ALP, ALT, AST, LDH, lipase, glucose, protein, cholesterol and triglyceride) and response of the endocrine system functioning in different axis, namely HPI (cortisol), HPT (TSH, T3, T4), gonadal (LH, FSH) and prolactin.
60 YEARS OF NEUROENDOCRINOLOGY: The hypothalamo-prolactin axis.
Auckland, New Zealand. In J Endocrinol, 31 Aug 2015
The hypothalamic control of prolactin secretion is different from other anterior pituitary hormones, in that it is predominantly inhibitory, by means of dopamine from the tuberoinfundibular dopamine neurons.
Managing Prolactinomas during Pregnancy.
Riyadh, Saudi Arabia. In Front Endocrinol (lausanne), Dec 2014
A dopamine agonist (DA) (bromocriptine or cabergoline) is the treatment of choice that can normalize prolactin levels, reduce tumor size, and restore ovulation and fertility.
The influence of atypical antipsychotic drugs on sexual function.
Piekary Śląskie, Poland. In Neuropsychiatr Dis Treat, Dec 2014
The relationship between atypical antipsychotic drugs and sexual dysfunction is mediated in part by antipsychotic blockade of pituitary dopamine D2 receptors increasing prolactin secretion, although direct correlations have not been established between raised prolactin levels and clinical symptoms.
Inclusion of endogenous hormone levels in risk prediction models of postmenopausal breast cancer.
More papers using
Boston, United States. In J Clin Oncol, Nov 2014
Therefore, we evaluated whether inclusion of plasma estradiol, estrone, estrone sulfate, testosterone, dehydroepiandrosterone sulfate, prolactin, and sex hormone-binding globulin (SHBG) improved risk prediction for postmenopausal invasive breast cancer (n = 437 patient cases and n = 775 controls not using postmenopausal hormones) in the Nurses' Health Study.